Преглед аутора: "Pokrajac, Milena"
Приказ резултата 1-20 од 58
-
Are moclobemide trough concentrations an adequate predictor of the systemic drug exposure
Rakić-Ignjatović, Anita; Miljković, Branislava; Todorović, Dejan; Timotijević, Ivana; Pokrajac, Milena (Elsevier Science BV, Amsterdam, 2008) -
Assessment of benzodiazepines-valproic acid pharmacokinetic interaction in adult epileptic patients: population approach
Vučićević, Katarina; Miljković, Branislava; Pokrajac, Milena; Prostran, Milica; Martinović, Žarko J.; Veličković, Ružica; Grabnar, Iztok (Elsevier Science BV, Amsterdam, 2010) -
Biopharmaceutics classification system (BCS) as a framework for selective approach to bioavailability/bioequivalence (BA/BE) investigation / Biofarmaceutski sistem klasifikacije (BSK) kao osnova za selektivni pristup ispitivanju biološke raspoloživosti/biološke ekvivalentnosti (BA/BE) farmaceutskih preparata
Petronijević, Marija; Pokrajac, Milena; Miljković, Branislava; Vučićević, Katarina (Savez farmaceutskih udruženja Srbije, Beograd, 2006) -
Characteristics of population pharmacokinetic approach with its importance in drug development and the therapy / Karakteristike populacionog farmakokinetičkog pristupa analizi podataka i njegov značaj u razvoju i primeni lekova
Vučićević, Katarina; Miljković, Branislava; Pokrajac, Milena; Petronijević, Marija (Savez farmaceutskih udruženja Srbije, Beograd, 2005) -
The clinical pharmacological correlation between amitriptyline dosage and side effects / Kliničko-farmakološka korelacija doza amitriptilina i neželjenih efekata
Timotijević-Marković, Ivana; Pokrajac, Milena; Miljković, Branislava; Stojković, Mirjana; Veličković, Ružica (Institut za mentalno zdravlje, Beograd, 1992) -
Clinical response and plasma concentrations of amitriptyline and its metabolite-nortriptyline in depressive patients
Miljković, Branislava; Pokrajac, Milena; Timotijević, Ivana; Varagić, V.M. (Medecine Et Hygiene, Geneva 4, 1996) -
Clinical significance of drug interactions and adverse drug reactions in gastrointestinal disorders / Klinički značaj interakcija i neželjenih efekata gastrointestinalnih lekova
Miljković, Branislava; Pokrajac, Milena (Savez farmaceutskih udruženja Srbije, Beograd, 2004) -
Clinically important interactions of antibiotics and antifungal drugs with other drugs / Klinički značajne interakcije antibiotika i antimikotika sa drugim lekovima
Miljković, Branislava; Vučićević, Katarina; Pokrajac, Milena (Savez farmaceutskih udruženja Srbije, Beograd, 2007) -
Clinically significant CYP 450 mediated drug: Drug interactions / Klinički značajnije CYP 450 posredovane lek - lek interakcije
Vučićević, Katarina; Miljković, Branislava; Petronijević, M.; Pokrajac, Milena (Savez farmaceutskih udruženja Srbije, Beograd, 2006) -
Comparative biovailability of two oral propafenone preparations
Pokrajac, Milena; Miljković, Branislava (Pharmaca, 1991) -
Comparative pharmacokinetics and bioavailability of two cotrimoxazole preparations
Pokrajac, Milena; Miljković, Branislava; Simić, D; Brzaković, B; Galetin, A (Govi-Verlag Gmbh, Eschborn, 1998) -
The comparison of the spectrodensitometric determination of theophylline to HPLC, RIA and EMIT procedures
Pokrajac, Milena; Agbaba, Danica; Varagić, V.M.; Glisović, L (Acta Pharmaceutica Jugoslavica, 1986) -
Correlation between dose and plasma concentrations of lamotrigine in adult patients and children with epilepsy
Brzaković, Branka; Pokrajac, Milena; Miljković, Branislava; Martinović, Žarko J.; Veličković, Ružica (Springer, Dordrecht, 2007) -
Cytochrome P450: Genetic polymorphism in drug metabolism / Citohrom P450: genetički polimorfizam u metabolizmu lekova
Rakić, Anita; Pokrajac, Milena; Miljković, Branislava (Savez farmaceutskih udruženja Srbije, Beograd, 2002) -
Dependence of the Renal Excretion of Theophylline on its Plasma Concentrations and Urine Flow Rate in Asthmatic Children
Agbaba, Danica; Pokrajac, Milena; Varagić, V.M.; Pešić, V. (Journal of Pharmacy and Pharmacology, 1990) -
Determination of Moclobemide and its Metabolites in Human Plasma by SPE-HPLC-UV: Evaluation of Critical Experimental Conditions and QSRR Study
Rakić-Ignjatović, Anita; Nikolić, Katarina; Miljković, Branislava; Pokrajac, Milena; Agbaba, Danica; Prostran, Milica (Taylor & Francis Inc, Philadelphia, 2009) -
Disposition of Lamotrigine in children with epilepsy receiving politherapy / Dispozicija Lamotrigina u kombinovano terapiji dece sa epilepsijom
Brzaković, Branka; Pokrajac, Milena; Martinović, Žarko J.; Veličković, Ružica; Miljković, Branislava; Varagić, V.M. (Savez farmaceutskih udruženja Srbije, Beograd, 2002) -
The effect of carbamazepine co-therapy on the extent of MAO-A inhibition by moclobemide in depressed patients
Rakić-Ignjatović, Anita; Miljković, Branislava; Todorović, Dejan; Timotijević, Ivana; Pokrajac, Milena (Elsevier Science BV, Amsterdam, 2010) -
Effect of co-treatment with valproic acid on carbamazepine elimination in epileptic patients a population pharmacokinetic study
Vučićević, Katarina; Miljković, Branislava; Petronijević, Marija; Pokrajac, Milena; Mrhar, Ales; Grabnar, Iztok (Springer, Dordrecht, 2008) -
Effect of patient weight and carbamazepine daily dose on carbamazepine clearance-a population pharmacokinetic study
Vučićević, Katarina; Miljković, Branislava; Pokrajac, Milena; Grabnar, Iztok (Springer, Dordrecht, 2009)